D.E. Shaw & Co
IDXX icon

D.E. Shaw & Co’s Idexx Laboratories IDXX Stock Holding History

D.E. Shaw & Co’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,074
Closed -$603K – 5036
2026
Q1 		$603K Sell
1,074
-560
-34% -$359K ﹤0.01% 3754
2025
Q4 		$1.11M Buy
1,634
+1,281
+363% +$872K ﹤0.01% 3470
2025
Q3 		$226K Sell
353
-22,304
-98% -$13.5M ﹤0.01% 4233
2025
Q2 		$12.2M Sell
22,657
-215,577
-90% -$103M 0.01% 1347
2025
Q1 		$100M Buy
238,234
+26,098
+12% +$11.3M 0.09% 274
2024
Q4 		$87.7M Buy
212,136
+85,921
+68% +$37.7M 0.06% 363
2024
Q3 		$63.8M Buy
126,215
+100,309
+387% +$48.7M 0.05% 420
2024
Q2 		$12.6M Sell
25,906
-89,766
-78% -$45.1M 0.01% 1184
2024
Q1 		$62.5M Buy
115,672
+67,606
+141% +$36.9M 0.05% 408
2023
Q4 		$26.7M Buy
48,066
+45,194
+1,574% +$21.2M 0.02% 768
2023
Q3 		$1.26M Buy
+2,872
New +$1.43M ﹤0.01% 2922
2022
Q4 		– Sell
-40,821
Closed -$13.3M – 4967
2022
Q3 		$13.3M Buy
40,821
+23,803
+140% +$8.74M 0.02% 1130
2022
Q2 		$5.97M Buy
17,018
+13,865
+440% +$5.65M 0.01% 1919
2022
Q1 		$1.73M Buy
3,153
+2,700
+596% +$1.42M ﹤0.01% 3443
2021
Q4 		$298K Sell
453
-299
-40% -$188K ﹤0.01% 4680
2021
Q3 		$468K Buy
752
+300
+66% +$202K ﹤0.01% 4126
2021
Q2 		$285K Sell
452
-636
-58% -$351K ﹤0.01% 4308
2021
Q1 		$532K Buy
1,088
+636
+141% +$319K ﹤0.01% 3475
2020
Q4 		$226K Sell
452
-200
-31% -$89.5K ﹤0.01% 3700
2020
Q3 		$256K Buy
+652
New +$241K ﹤0.01% 3519
2020
Q1 		– Sell
-72,672
Closed -$19M – 4077
2019
Q4 		$19M Buy
72,672
+68,694
+1,727% +$18.1M 0.02% 842
2019
Q3 		$1.08M Sell
3,978
-9,101
-70% -$2.53M ﹤0.01% 2783
2019
Q2 		$3.6M Sell
13,079
-23,682
-64% -$5.84M ﹤0.01% 1838
2019
Q1 		$8.22M Sell
36,761
-119,900
-77% -$24.8M 0.01% 1233
2018
Q4 		$29.1M Buy
156,661
+90,857
+138% +$18.6M 0.04% 539
2018
Q3 		$16.4M Buy
65,804
+9,468
+17% +$2.3M 0.02% 866
2018
Q2 		$12.3M Buy
56,336
+18,790
+50% +$3.87M 0.02% 975
2018
Q1 		$7.19M Sell
37,546
-5,683
-13% -$1.05M 0.01% 1188
2017
Q4 		$6.76M Buy
43,229
+13,996
+48% +$2.2M 0.01% 1278
2017
Q3 		$4.54M Sell
29,233
-9,924
-25% -$1.57M 0.01% 1449
2017
Q2 		$6.32M Buy
39,157
+34,862
+812% +$5.66M 0.01% 1170
2017
Q1 		$664K Sell
4,295
-4,164
-49% -$574K ﹤0.01% 2576
2016
Q4 		$992K Sell
8,459
-98,167
-92% -$11.2M ﹤0.01% 2461
2016
Q3 		$12M Buy
106,626
+68,285
+178% +$7.2M 0.02% 793
2016
Q2 		$3.56M Buy
+38,341
New +$3.29M 0.01% 1508
2014
Q4 		– Sell
-28,752
Closed -$2.02M – 4111
2014
Q3 		$1.69M Sell
28,752
-201,618
-88% -$12.7M ﹤0.01% 2364
2014
Q2 		$15.4M Buy
230,370
+165,464
+255% +$10.5M 0.02% 839
2014
Q1 		$3.94M Sell
64,906
-11,918
-16% -$710K 0.01% 1768
2013
Q4 		$4.09M Buy
76,824
+72,420
+1,644% +$3.81M 0.01% 1865
2013
Q3 		$219K Sell
4,404
-8,230
-65% -$396K ﹤0.01% 4051
2013
Q2 		$567K Buy
+12,634
New +$552K ﹤0.01% 3153

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

D.E. Shaw & Co's IDXX Position: Q2 2026 in Review

D.E. Shaw & Co sold out of Idexx Laboratories (IDXX) in Q2 2026, closing a stake of 1,074 shares — an estimated $603K sold.

D.E. Shaw & Co first reported a position in IDXX in Q2 2013 and held it in 41 quarters. The position peaked at $100M in Q1 2025. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • D.E. Shaw & Co reported no remaining Idexx Laboratories position as of Q2 2026 after selling out during the quarter.
  • D.E. Shaw & Co sold 1,074 Idexx Laboratories shares in Q2 2026, an estimated $603K.
  • D.E. Shaw & Co first reported a position in Idexx Laboratories in Q2 2013 and held it in 41 quarters.
  • D.E. Shaw & Co's Idexx Laboratories position peaked at $100M in Q1 2025.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.